These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 39120320)

  • 1. Culture and Immunomodulation of Equine Muscle-Derived Mesenchymal Stromal Cells: A Comparative Study of Innovative 2D versus 3D Models Using Equine Platelet Lysate.
    Duysens J; Graide H; Niesten A; Mouithys-Mickalad A; Deby-Dupont G; Franck T; Ceusters J; Serteyn D
    Cells; 2024 Jul; 13(15):. PubMed ID: 39120320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet lysate as a novel serum-free media supplement for the culture of equine bone marrow-derived mesenchymal stem cells.
    Naskou MC; Sumner SM; Chocallo A; Kemelmakher H; Thoresen M; Copland I; Galipeau J; Peroni JF
    Stem Cell Res Ther; 2018 Mar; 9(1):75. PubMed ID: 29566772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous Platelet Lysate Does Not Enhance Chondrogenic Differentiation of Equine Bone Marrow-Derived Mesenchymal Stromal Cells Despite Increased TGF-β1 Concentration.
    Chapman HS; Gale AL; Dodson ME; Linardi RL; Ortved KF
    Stem Cells Dev; 2020 Feb; 29(3):144-155. PubMed ID: 31802705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen-Depleted Equine Platelet Lysate Affects the Characteristics and Functionality of Mesenchymal Stem Cells.
    Naskou MC; Sumner S; Berezny A; Copland IB; Peroni JF
    Stem Cells Dev; 2019 Dec; 28(23):1572-1580. PubMed ID: 31637965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of allogeneic platelet lysate on equine bone marrow derived mesenchymal stem cell characteristics, including immunogenic and immunomodulatory gene expression profile.
    Yaneselli K; Barrachina L; Remacha AR; Algorta A; Vitoria A; Cequier A; Romero A; Vázquez FJ; Maisonnave J; Rodellar C
    Vet Immunol Immunopathol; 2019 Nov; 217():109944. PubMed ID: 31563725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle Derived Mesenchymal Stem Cells Inhibit the Activity of the Free and the Neutrophil Extracellular Trap (NET)-Bond Myeloperoxidase.
    Franck T; Ceusters J; Graide H; Mouithys-Mickalad A; Serteyn D
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scalable Production of Equine Platelet Lysate for Multipotent Mesenchymal Stromal Cell Culture.
    Hagen A; Lehmann H; Aurich S; Bauer N; Melzer M; Moellerberndt J; Patané V; Schnabel CL; Burk J
    Front Bioeng Biotechnol; 2020; 8():613621. PubMed ID: 33553119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine platelet lysate as an alternative to fetal bovine serum in equine mesenchymal stromal cell culture - too much of a good thing?
    Russell KA; Koch TG
    Equine Vet J; 2016 Mar; 48(2):261-4. PubMed ID: 25772755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine and Equine Mesenchymal Stem Cells Grown in Serum Free Media Have Altered Immunophenotype.
    Clark KC; Kol A; Shahbenderian S; Granick JL; Walker NJ; Borjesson DL
    Stem Cell Rev Rep; 2016 Apr; 12(2):245-56. PubMed ID: 26638159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-free human MSC medium supports consistency in human but not in equine adipose-derived multipotent mesenchymal stromal cell culture.
    Schubert S; Brehm W; Hillmann A; Burk J
    Cytometry A; 2018 Jan; 93(1):60-72. PubMed ID: 28926198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of the Amplification of Equine Muscle-Derived Mesenchymal Stromal Cells in a Hollow-Fiber Bioreactor.
    Duysens J; Graide H; Niesten A; Mouithys-Mickalad A; Ceusters J; Serteyn D
    Methods Protoc; 2024 Apr; 7(2):. PubMed ID: 38668139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The production method affects the efficacy of platelet derivatives to expand mesenchymal stromal cells in vitro.
    Bernardi M; Agostini F; Chieregato K; Amati E; Durante C; Rassu M; Ruggeri M; Sella S; Lombardi E; Mazzucato M; Astori G
    J Transl Med; 2017 May; 15(1):90. PubMed ID: 28460641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the immunomodulatory properties of equine BM-MSCs culture expanded in autologous platelet lysate, pooled platelet lysate, equine serum and fetal bovine serum supplemented culture media.
    Even KM; Gaesser AM; Ciamillo SA; Linardi RL; Ortved KF
    Front Vet Sci; 2022; 9():958724. PubMed ID: 36090170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: a Biomedical Excellence for Safer Transfusion (BEST) collaborative study.
    Shaz BH; Schäfer R; Fontaine MJ; Norris PJ; McKenna DH; Jin P; Reems JA; Stroncek D; Tanashi M; Marks D; Geng H; Pati S;
    Cytotherapy; 2024 Jun; 26(6):531-539. PubMed ID: 38043052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of allogeneic platelet lysate and fetal bovine serum for in vitro expansion of equine bone marrow-derived mesenchymal stem cells.
    Seo JP; Tsuzuki N; Haneda S; Yamada K; Furuoka H; Tabata Y; Sasaki N
    Res Vet Sci; 2013 Oct; 95(2):693-8. PubMed ID: 23683731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice of xenogenic-free expansion media significantly influences the myogenic differentiation potential of human bone marrow-derived mesenchymal stromal cells.
    Brun J; Abruzzese T; Rolauffs B; Aicher WK; Hart ML
    Cytotherapy; 2016 Mar; 18(3):344-59. PubMed ID: 26857228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience.
    Becherucci V; Piccini L; Casamassima S; Bisin S; Gori V; Gentile F; Ceccantini R; De Rienzo E; Bindi B; Pavan P; Cunial V; Allegro E; Ermini S; Brugnolo F; Astori G; Bambi F
    Stem Cell Res Ther; 2018 May; 9(1):124. PubMed ID: 29720245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions.
    Castiglia S; Mareschi K; Labanca L; Lucania G; Leone M; Sanavio F; Castello L; Rustichelli D; Signorino E; Gunetti M; Bergallo M; Bordiga AM; Ferrero I; Fagioli F
    Cytotherapy; 2014 Jun; 16(6):750-63. PubMed ID: 24529555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Platelet Lysate Supports Efficient Expansion and Stability of Wharton's Jelly Mesenchymal Stromal Cells via Active Uptake and Release of Soluble Regenerative Factors.
    Cañas-Arboleda M; Beltrán K; Medina C; Camacho B; Salguero G
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32877987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
    Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
    BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.